George S. Baillie

15.4k total citations · 2 hit papers
205 papers, 10.9k citations indexed

About

George S. Baillie is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, George S. Baillie has authored 205 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Molecular Biology, 54 papers in Pharmacology and 32 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in George S. Baillie's work include Phosphodiesterase function and regulation (124 papers), Receptor Mechanisms and Signaling (94 papers) and Cholinesterase and Neurodegenerative Diseases (53 papers). George S. Baillie is often cited by papers focused on Phosphodiesterase function and regulation (124 papers), Receptor Mechanisms and Signaling (94 papers) and Cholinesterase and Neurodegenerative Diseases (53 papers). George S. Baillie collaborates with scholars based in United Kingdom, United States and Germany. George S. Baillie's co-authors include Miles D. Houslay, Laura Douglas, Simon J. MacKenzie, Ian McPhee, Elaine Huston, Donald H. Maurice, Martin J. Lynch, Graeme B. Bolger, Gonzalo S. Tejeda and Berit Adam and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

George S. Baillie

202 papers receiving 10.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

2005 507 citations J. Kirsty Millar, Ben Pickard et al. Science profile →
Targeting of Cyclic AMP Degradation to β ₂ -Adrenergic Receptors by β-Arrestins

2002 390 citations Stephen J. Perry, George S. Baillie et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George S. Baillie United Kingdom	58	8.3k	1.9k	1.4k	1.1k	1.1k	205	10.9k
Mariko Saito Japan	50	3.8k 0.5×	498 0.3×	1.2k 0.9×	574 0.5×	738 0.7×	383	8.7k
Nigel M. Hooper United Kingdom	73	9.2k 1.1×	1.5k 0.8×	1.9k 1.3×	3.0k 2.7×	2.2k 2.0×	281	18.2k
Hisashi Fujioka United States	60	5.8k 0.7×	586 0.3×	1.2k 0.8×	363 0.3×	616 0.6×	193	12.0k
Richard D. Ye United States	65	7.2k 0.9×	809 0.4×	975 0.7×	487 0.4×	313 0.3×	245	13.4k
David Baker United Kingdom	64	4.8k 0.6×	3.3k 1.7×	2.4k 1.7×	269 0.2×	616 0.6×	296	15.4k
Norman J. Haughey United States	58	5.4k 0.6×	504 0.3×	1.5k 1.0×	271 0.2×	956 0.9×	188	11.8k
Masahiko Fujino Japan	60	5.6k 0.7×	2.4k 1.3×	5.5k 3.8×	1.3k 1.1×	420 0.4×	260	14.9k
Zhan‐Guo Gao United States	63	9.7k 1.2×	710 0.4×	2.3k 1.6×	919 0.8×	280 0.3×	259	16.7k
Jacques Grassi France	54	5.4k 0.7×	1.3k 0.7×	610 0.4×	221 0.2×	920 0.8×	206	8.9k
Scott G. Morham United States	37	3.4k 0.4×	3.2k 1.7×	413 0.3×	294 0.3×	553 0.5×	50	9.1k

Countries citing papers authored by George S. Baillie

Since Specialization

Citations

This map shows the geographic impact of George S. Baillie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George S. Baillie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George S. Baillie more than expected).

Fields of papers citing papers by George S. Baillie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George S. Baillie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George S. Baillie. The network helps show where George S. Baillie may publish in the future.

Co-authorship network of co-authors of George S. Baillie

This figure shows the co-authorship network connecting the top 25 collaborators of George S. Baillie. A scholar is included among the top collaborators of George S. Baillie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George S. Baillie. George S. Baillie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hussain, M. Mahmood, Gonzalo S. Tejeda, & George S. Baillie. (2025). Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting. FEBS Journal. 292(23). 6182–6194.

Montezano, Augusto C., Yuan Yan Sin, Lívia L. Camargo, et al.. (2024). Ang-(1-7) and ET-1 Interplay Through Mas and ET _B Receptor Interaction Defines a Novel Vasoprotective Mechanism. Hypertension. 82(2). 267–281. 2 indexed citations

Lipina, Tatiana V., Shupeng Li, Tamara G. Amstislavskaya, et al.. (2024). PDE4B Missense Variant Increases Susceptibility to Post-traumatic Stress Disorder-Relevant Phenotypes in Mice. Journal of Neuroscience. 44(43). e0137242024–e0137242024. 4 indexed citations

Huss, Sebastian, et al.. (2023). Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies. British Journal of Cancer. 129(9). 1462–1476. 1 indexed citations

Dupré, Denis J., et al.. (2023). Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119520–119520. 6 indexed citations

Paes, Dean, Melissa Schepers, Ben Rombaut, et al.. (2023). Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology. Cellular and Molecular Life Sciences. 80(7). 178–178. 13 indexed citations

Ishikawa, Kiyotake, Kelly P. Yamada, Ah Young Lee, et al.. (2022). SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca²⁺. FEBS Journal. 289(20). 6267–6285. 3 indexed citations

Paradis, Justine S., Kusumika Saha, Cédric Auffray, et al.. (2021). The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis. Oncogene. 40(12). 2243–2257. 16 indexed citations

Tejeda, Gonzalo S., et al.. (2019). PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders. Cellular Signalling. 60. 31–38. 6 indexed citations

10.

Williams, Jamie J.L., William Mullen, Richard Burchmore, et al.. (2018). Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability. Nature Communications. 9(1). 168–168. 23 indexed citations

11.

Frank, Christian, Eberhard Krause, Miles D. Houslay, & George S. Baillie. (2014). PKA phosphorylation of p62/SQSTM1 regulates PB1 domain interaction partner binding. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(11). 2765–2774. 38 indexed citations

12.

Quinn, Steven D., Paul A. Dalgarno, Ryan T. Cameron, et al.. (2013). Real-time probing of β-amyloid self-assembly and inhibition using fluorescence self-quenching between neighbouring dyes. Molecular BioSystems. 10(1). 34–44. 37 indexed citations

13.

Kean, Michelle J., Derek F. Ceccarelli, Marilyn Goudreault, et al.. (2011). Structure-Function Analysis of Core STRIPAK Proteins. Journal of Biological Chemistry. 286(28). 25065–25075. 122 indexed citations

14.

Bjørgo, Elisa, Hilde Abrahamsen, George S. Baillie, et al.. (2010). Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/β-Arrestin/cAMP Phosphodiesterase 4 Complex. Molecular and Cellular Biology. 30(7). 1660–1672. 57 indexed citations

15.

Collins, D.M., Hannah Murdoch, Allan J. Dunlop, et al.. (2008). Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA). Cellular Signalling. 20(12). 2356–2369. 34 indexed citations

16.

Millar, J. Kirsty, Ben Pickard, Shaun Mackie, et al.. (2005). DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling. Science. 310(5751). 1187–1191. 507 indexed citations breakdown →

17.

Abrahamsen, Hilde, George S. Baillie, Torkel Vang, et al.. (2004). TCR- and CD28-Mediated Recruitment of Phosphodiesterase 4 to Lipid Rafts Potentiates TCR Signaling. The Journal of Immunology. 173(8). 4847–4858. 115 indexed citations

18.

Baillie, George S., et al.. (2004). Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers. American Journal of Physiology-Lung Cellular and Molecular Physiology. 287(2). L332–L343. 93 indexed citations

19.

Perry, Stephen J., George S. Baillie, Trudy A. Kohout, et al.. (2002). Targeting of Cyclic AMP Degradation to β ₂ -Adrenergic Receptors by β-Arrestins. Science. 298(5594). 834–836. 390 indexed citations breakdown →

20.

Baillie, George S., Simon J. MacKenzie, Ian McPhee, & Miles D. Houslay. (2000). Sub‐family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP‐specific phosphodiesterases. British Journal of Pharmacology. 131(4). 811–819. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact